419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
First Quarter 2026 Earnings & Corporate Update
Financial Results, Press Release
Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Liquidia Technologies Enters Exclusive Licensing Agreement with Vectura
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
News
Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
Q1
FY 2025
Q3
Q2
FY 2024
S-3ASR
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Free Writing Prospectus